ShareCompartir
Feature
Two Epidemics. One Mission.
How We Do It.
HIV and Tuberculosis (TB) are the world’s two most deadly infectious diseases. Additionally, these two epidemics are tragically interconnected, as TB is the leading cause of death for those living with HIV.
At the Division of Global HIV & TB (DGHT), we are tackling these two epidemics to produce the greatest impact. DGHT experts are working on the front lines in more than 45 countries and regions around the globe, focused on a single mission: to fight these diseases and, ultimately, bring an end to the dual epidemics of HIV and TB worldwide.
Where We Work
What We Do
CDC's Results
Our Results
Worldwide, HIV and TB are a deadly combination.
CDC and partners are making a powerful impact
against these two diseases.
*Other USG agencies may have also contributed
**As of Sept 30, 2017
***FY2017 | ****Cumulative through Sept 30, 2017
Sources: U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
7.5 Million
Men have received voluntary medical circumcision procedures****
1.8 Million
People who received a positive HIV test result***
7.3 Million
Men, women and children who have received life-saving HIV treatment**
4.7 Million
HIV-Positive Persons
Screened in Care for TB***
450,000+
Women who were treated to help reduce
risk of mother-to-child HIV transmission***
CDC’s Contributions
Antiretroviral Treatment for
Men, Women,
and Children**
PEPFAR: 13.3 Million
CDC: 7.3 Million
Antiretroviral Treatment to
Prevent Mother-to-child Transmission***
PEPFAR: 792,712
CDC: 450,000+
Voluntary Medical Male Circumcisions
(VMMC)****
PEPFAR: 15.2 Million
CDC: 7.5 Million
HIV-Positive Persons Screened in Care for TB***
PEPFAR: 7 Million
CDC: 4.7 Million
People Who Received a
Positive HIV Test Result***
PEPFAR: 3.3 Million
CDC: 1.8 Million
Sources: U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
*Other USG agencies may have also contributed to some of these achievements **As of Sept 30, 2017 ***FY2017 ****Cumulative through Sept 30, 2017
What’s New
- Page last reviewed: November 26, 2018, 02:50 PM
- Page last updated: November 26, 2018, 02:50 PM
- Content source:
